Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 6291-02-7 Chemical Structure| 6291-02-7

Structure of 6291-02-7

Chemical Structure| 6291-02-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 6291-02-7 ]

CAS No. :6291-02-7
Formula : C7H6Cl2O2S
M.W : 225.09
SMILES Code : CC1=C(Cl)C=CC(=C1)S(Cl)(=O)=O
MDL No. :MFCD04117295
InChI Key :WEPYREBDJIVOHD-UHFFFAOYSA-N
Pubchem ID :221001

Safety of [ 6291-02-7 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H314
Precautionary Statements:P280-P305+P351+P338
Class:8
UN#:1759
Packing Group:

Computational Chemistry of [ 6291-02-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 49.5
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

42.52 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.04
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.36
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.66
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.43
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.42
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.78

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.66
Solubility 0.0497 mg/ml ; 0.000221 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.93
Solubility 0.0264 mg/ml ; 0.000117 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.95
Solubility 0.0253 mg/ml ; 0.000112 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.29 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.84

Application In Synthesis of [ 6291-02-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 6291-02-7 ]

[ 6291-02-7 ] Synthesis Path-Downstream   1~22

  • 3
  • [ 6291-02-7 ]
  • [ 19482-16-7 ]
  • 4
  • [ 6291-02-7 ]
  • [ 60310-05-6 ]
  • 5
  • [ 46059-90-9 ]
  • [ 6291-02-7 ]
  • 8
  • 6-chloro-toluene-sulfonic acid-(3) [ No CAS ]
  • [ 6291-02-7 ]
  • 9
  • sodium salt of/the/ 6-chloro-toluene-sulfonic acid-(3) [ No CAS ]
  • [ 6291-02-7 ]
  • 10
  • [ 10026-13-8 ]
  • [ 6291-02-7 ]
  • [ 7782-50-5 ]
  • 2-chloro-5-chloromethyl-benzenesulfonyl chloride [ No CAS ]
  • 11
  • [ 6291-02-7 ]
  • 4-chloro-3-methylphenyl chloromethyl sulfide [ No CAS ]
  • 12
  • [ 6291-02-7 ]
  • 1-Chloro-2-methyl-4-((1R,2R)-2-phenyl-cyclopropylsulfanyl)-benzene [ No CAS ]
  • 13
  • [ 6291-02-7 ]
  • 1-Chloro-2-methyl-4-((1R,2R)-2-phenyl-cyclopropanesulfonyl)-benzene [ No CAS ]
  • 14
  • [ 6291-02-7 ]
  • [ 96-92-4 ]
  • 15
  • [ 6291-02-7 ]
  • 5-Aminotoluol-3-sulfonsaeure [ No CAS ]
  • 16
  • [ 98-33-9 ]
  • [ 6291-02-7 ]
  • 17
  • [ 30273-23-5 ]
  • [ 6291-02-7 ]
YieldReaction ConditionsOperation in experiment
Example 67: 4-Chloro-3-methylsulfonylchloride; [00464] Iron powder (150 g, 2.68 mol) and AcOH (600 mL) were charged into a 2 L round bottom flask equipped with a mechanical stirrer and thermometer. The mixture as warmed to 80 C. 4-Chloro-3-methylnitrobenzene (150 g, 0.87 mol) in AcOH (200 mL) was added slowly to the flask over 4 h, keeping the reaction temperature below 90 C. Upon consumption of the reactants, the mixture was filtered through a pad of Celite and the filter cake was washed with methanol (200 mL). The filtrate was concentrated and the residue was poured into 1.5 L of ice water (1 :1) and the resulting precipitate was filtered. The crude product was dissolved in 300 mL 6N HCI in water/dioxane (1 :1) and stirred at 100 C for 3 h. It was then cooled to room temperature and the precipitate was filtered and dried to provide 130 g of 4-chloro-3-methyl- phenylamine hydrochloride as a colorless powder. [00465] 4-Chloro-3-methylaniline hydrochloride (75 g, 0.54 mol) was dissolved in 200 mL concentrated hydrochloride acid (200 mL) and acetic acid (60 mL). The mixture was cooled to -5 C and NaNO2 (40.9 g, 0.59 mmol) was added. The mixture was stirred between -10 C to -5 C for 1 h. While the EPO <DP n="142"/>diazotization was in progress, glacial AcOH (600 mL) was placed in a 4000-mL beaker and stirred magnetically. Sulfur dioxide was introduced by a bubbler tube with a fritted end immersed below the surface of the AcOH until saturation was evident. Cuprous chloride (15 g) was added to the solution. The introduction of sulfur dioxide was continued until the yellow-green suspension becomes blue- green. The mixture was then placed in an ice bath and cooled to 10 C. The diazotization reaction mixture was subsequently added in portions over a 30 min period to the sulfur dioxide solution, ensuring the temperature of the solution did not exceed 30 C. After all the diazonium salt mixture was added, the mixture was poured into ice water (2 L). The resulting precipitate was filtered and re- dissolved in hexane (500 mL). The mixture was filtered through a pad of silica gel (100 g) and the filter pad was washed with hexane (300 mL). The combined filtrate was concentrated to yield 50 g of 4-chloro-3~methylbenzenesulfonyl chloride as slightly yellow solid.
  • 18
  • [ 90902-83-3 ]
  • [ 6291-02-7 ]
  • [ 899424-36-3 ]
YieldReaction ConditionsOperation in experiment
Example 69: N-(2-Bromo-5-chloro-pyridin-3-yl)-4-chloro-N-methoxymethyl-3- methyl-benzenesulfonamide; [00468] To a stirred solution of 2-bromo-5-chloro-pyridin-3-ylamine (4.12 g, 20 mmol) in anhydrous pyridine (100 mL) was added 3~methyl-4- chlorobenzenesulfonyl chloride (6.35 g, 26 mmol) and the progress of the reaction was followed by LCMS. The reaction mixture was stirred overnight (18 h), then concentrated to remove as much of the pyridine as possible. The residue was dissolved in THF and was stirred 18h with aqueous sodium hydroxide (20 mL) in THF to cleave the bis-sulfonamide. The reaction mixture was subsequently neutralized with aqueous HCI and extracted with EtOAc; the EPO <DP n="144"/>organic phase was washed with water (2 x 100 mL), brine, and then dried (MgSO4), filtered, and concentrated under reduced pressure. The residue was purified by chromatography on silica gel using EtOAc-hexane to provide N-(2- bromo-5-chloro-pyridin-3-yl)-4-chloro-3-methyl-benzenesulfonamide as a white crystalline solid. MS m/z 397.1 (M + H).[00469] Methoxymethyl chloride (1.2 g, 14.3 mmol) was added dropwise to a mixture of N-(2-bromo-5-chloro-pyridin-3-yl)-4-chloro-3-methyl- benzenesulfonamide (5.0 g, 12.7 mmol) and potassium carbonate (3.2 g, 23.2 mmol) in THF (30 mL) at room temperature. After 5 h, the potassium salts were removed by vacuum filtration and the filtrate was concentrated under reduced pressure. The residual light yellow solid was chromatographed on silica gel using ethyl acetate-hexane to provide the N-(2-bromo-5-chloro-pyridin-3-yl)-4- chloro-N-methoxymethyl-3-methyl-benzenesulfonamide as white crystals. MS m/z 441.2 (M + H).
  • 19
  • [ 582-22-9 ]
  • [ 6291-02-7 ]
  • [ 126130-77-6 ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide; In water; (a) Preparation of 3-[N-(4-chloro-3-methylbenzenesulfonyl)]amino-2-phenylpropane To a mixture of 35 g of 3-amino-2-phenylpropane, 11.0 g of 95% sodium hydroxide and 500 ml of water, 59 g of <strong>[6291-02-7]4-chloro-3-methylbenezenesulfonyl chloride</strong> was added under ice cooling, and the resultant mixture was stirred for 1 hour. The precipitated crystals were collected by suction, washed with water and dried to obtain 79.2 g of the titled compound. mp: 73 to 74 C. 1 H--NMR spectrum (CDCl3 --TMS)delta: 2.4-(3H, s), 4.03-(2H, s), 5.2-(1H, s), 5.36-(1H, s), 7.2 to 7.7-(8H, m).
With sodium hydroxide; In water; a) Preparation of 3-[N-(4-chloro-3-methylbenzenesulfonyl)]-amino-2-phenylpropane To a mixture of 35 g of 3-amino-2-phenylpropane, 11.0 g of 95% sodium hydroxide and 500 ml of water, 59 g of <strong>[6291-02-7]4-chloro-3-methylbenezenesulfonyl chloride</strong> was added under ice cooling, and the resultant mixture was stirred for 1 hour. The precipitated crystals were collected by suction, washed with water and dried to obtain 79.2 g of the titled compound. mp: 73 to 74C 1H-NMR spectrum (CDCl 3-TMS)delta: 2.4 (3H, s), 4.03 (2H, s), 5.2 (1H, s), 5.36 (1H, s), 7.2 to 7.7 (8H, m)
  • 20
  • [ 6291-02-7 ]
  • C11H11ClN2O2S [ No CAS ]
  • 21
  • [ 6291-02-7 ]
  • [ 1296731-75-3 ]
  • 22
  • [ 6291-02-7 ]
  • [ 5930-94-9 ]
  • C11H9ClN2O4S [ No CAS ]
 

Historical Records

Technical Information

Categories